MyEClinic
MyEClinic
Health Dictionary Find a Doctor

ICE-R regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:R-ICE Regimen; RICE Regimen; Rituximab-Ifosfamide-Carboplatin-Etoposide Regimen

Overview

ICE-R regimen refers to a chemoimmunotherapy regimen consisting of rituximab, ifosfamide, carboplatin and etoposide used to treat indolent and aggressive forms of non-Hodgkin’s lymphoma; also used to treat relapsed and refractory non-Hodgkin’s lymphoma.[1][2]

Regimen

RRituximab

IIfosfamide

CCarboplatin

EEtoposide

Indications

References

  1. ↑ 1.0 1.1 Vose J, Sneller V (2003). “Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma”. Ann Oncol. 14 Suppl 1: i17–20. PMID 12736226.
  2. ↑ “NCI Thesaurus”.

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH